期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | TRANSPLANTATION LetPub Score 7.8
50 ratings
Rate
Reputation 8.7 Influence 6.7 Speed 9.7 | |||||||||||||||||||||
期刊簡稱 | TRANSPLANTATION | |||||||||||||||||||||
ISSN | 0041-1337 | |||||||||||||||||||||
E-ISSN | 1534-6080 | |||||||||||||||||||||
h-index | 191 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 9.40%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | http://journals.lww.com/transplantjournal/pages/default.aspx | |||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/TPA | |||||||||||||||||||||
開放訪問 | No | |||||||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | |||||||||||||||||||||
主題領域 | 医学 | |||||||||||||||||||||
出版國/地區 | UNITED STATES | |||||||||||||||||||||
發行頻率 | 月2回刊行 | |||||||||||||||||||||
創刊年 | 1963 | |||||||||||||||||||||
每年文章數 | 268每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 13.41% | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0041-1337%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | |||||||||||||||||||||
競爭力 * | 來自作者的數據: About 80% | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[TRANSPLANTATION] 的評論 | 撰寫評論 |
作者: 伏魔凯歌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 21:15:04 評論於 Review speed: 2.0 | Submission hit rate: 75.0 Experience sharing: 1(0) 讚! | 伏魔凯歌 |
作者: 百花莹莹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-05 17:31:57 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research topics: Organ transplant experience sharing: Approximately one month per round of review. One major revision was made(0) 讚! | 百花莹莹 |
作者: 暗月寺丹红 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-09 21:28:23 評論於 How long does it take to publish?(0) 讚! | 暗月寺丹红 |
作者: 百花莹莹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-12 12:45:18 評論於 Can we accept it directly after the renovation is completed?(0) 讚! | 百花莹莹 |
作者: 百花莹莹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-12 09:03:59 評論於 My decision on 11-21 is still in process and I haven't received any confirmation yet(0) 讚! | 百花莹莹 |
作者: 宗室芳蔼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-08 15:59:47 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Main research direction: organ transplantation; Transplantation experience sharing: Submitted on June 28, 2022, reviewed by two experts during the process, major revisions, requested extension of 1 month for additional experiments, accepted on December 7, 2022. Editor is very good, replies to emails very promptly (usually on the same day when working), borrowing from the advisor's words: reputable old journal(0) 讚! | 宗室芳蔼 |
作者: 宗室芳蔼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-08 09:39:31 評論於 It's very good that the magazine is quick in reviewing and approving external opinions(0) 讚! | 宗室芳蔼 |
作者: 珉林歌飞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-07 11:14:49 評論於 Review Speed: 1.0 Focus on Research Area: Organ Transplantation Experience Sharing Submitted on November 1, 2022, Decision in process, it's been almost 5 working days, anxiously waiting(0) 讚! | 珉林歌飞 |
作者: 宗室芳蔼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-07 10:33:21 評論於 Review Speed: 6.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Transplant Experience Sharing Submitted on 28th June, 2022, reviewed by two experts during the process. Major revisions were required, additional experiments were requested and an extension of one month was granted. Accepted on 7th December, 2022. The editor was very good, replied to emails very promptly (usually on the same day). In the words of my supervisor: a prestigious journal, reliable(0) 讚! | 宗室芳蔼 |
作者: 百花莹莹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-24 12:43:51 評論於 How many days for review? I have been under review for over a month(0) 讚! | 百花莹莹 |
作者: Martina Jeremy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-25 08:52:35 評論於 I refused(0) 讚! | Martina Jeremy |
作者: Martina Jeremy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-21 15:02:55 評論於 Decision in Process(0) 讚! | Martina Jeremy |
作者: Walter Marcellus 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 23:02:19 評論於 Decision in process. How will the results be one week later?(0) 讚! | Walter Marcellus |
作者: Martina Jeremy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-16 19:31:13 評論於 Heavy research focus: Transplantation; sharing liver transplantation experience: submitted on 6-21, not sure how it turned out(0) 讚! | Martina Jeremy |
作者: 宗室芳蔼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-04 18:06:09 評論於 Main Research Focus: Sharing experiences in transplantation. Please advise: Submitted on 6/28, status shows "Submissions Being Processed." Received confirmation email with manuscript number on 6/29. Status has been showing "Similarity Check/iThenticate Results (29%)" since then. Should I revise and resubmit for plagiarism reduction? Or should I wait for the editor's response? Thank you(0) 讚! | 宗室芳蔼 |
作者: 雾都景同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-04 13:25:41 評論於 It was accepted within half a day, the efficiency speed of Americans is quite different from that of European grandfathers, really(0) 讚! | 雾都景同 |
作者: 岭南佩杉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-11 23:53:25 評論於 Do we need to select "yes" for open access? Do we need to upload a form if we choose "yes"? I have never encountered this in other journals(0) 讚! | 岭南佩杉 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:32:56 評論於 Medical Subject Headings (MeSH) is a metadata system published by the United States National Library of Medicine, widely used for medical information retrieval. It is used in the field of life sciences for indexing journal articles and books. The main purpose of MeSH is to classify the vast amount of literature in PubMed/MEDLINE(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:46:21 評論於 In the field of medicine, most journals and clinical papers particularly recommend the use of MeSH. Using MeSH terms is to help with literature searches and increase the weight of publications(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:05:10 評論於 Why screen keywords from MeSH?(0) 讚! | 平原文波 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:48:43 評論於 What is MeSH?(0) 讚! | 魂魄彦露 |
作者: 岭南佩杉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-02 08:47:17 評論於 Hello, thank you for your reply. I see that you are also doing basic research on liver transplantation. Can I further consult with you? ? I have sent you a private message(0) 讚! | 岭南佩杉 |
作者: 排云冠宇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-28 20:51:41 評論於 Do not subjectively guess whether the reviewers and editors like or dislike your article. Respond to all review comments item by item with a learning attitude, trying your best to supplement experiments according to the review comments. Good articles are never written, they are revised. Let the reviewers and editors see your attitude and sincerity in revising, and the article can naturally be published smoothly. After revision, it will be sent back to the original editors and reviewers for a second review. Hope this is helpful to you(0) 讚! | 排云冠宇 |
作者: 岭南佩杉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-27 19:20:58 評論於 Hello, I am currently in major revision status. However, one reviewer suggested minor revisions while another suggested major revisions, but both stated that the article is acceptable. I am confused as to why the editor's comments seem to indicate a dislike for the article. Also, I am unsure if the major revisions are to be addressed to the original reviewer or a new reviewer. I would appreciate your response. Thank you(0) 讚! | 岭南佩杉 |
作者: 排云冠宇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-13 08:07:19 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Emphasized research direction: Liver transplantation experience sharing: Liver transplantation basic research, article submitted on April 6, 2021; major revision on May 5, 2021, revised second review on June 30, 2021; minor revision on July 17, 2021, revised on July 28, 2021 Accepted on August 17, 2021! Experience: 2 professional editors + 2 reviewers, rigorous review process, professional questioning! Do not have a lucky mentality, be sure to improve the manuscript, ensure quality before considering submission! This will greatly shorten the submission cycle and increase the probability of acceptance(0) 讚! | 排云冠宇 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us